Medical treatment of viral pneumonia including SARS in immunocompetent adult

Journal of Infection

Volumn 49, Issue 4, 2004, Pages 262-273

  Cheng, V C C ^a   Tang, B S F ^a   Wu, A K L ^a   Chu, C M ^b   Yuen, K Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

Immunocompetent host; SARS; Treatment; Viral pneumonia

Indexed keywords

ACICLOVIR; AMANTADINE; ANTIVIRUS AGENT; CONSENSUS INTERFERON; CORTICOSTEROID; HYDROCORTISONE; IMMUNOGLOBULIN; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; OSELTAMIVIR; PREDNISOLONE; RECOMBINANT ALPHA INTERFERON; RETINOL; RIBAVIRIN; RIMANTADINE; STEROID; VIDARABINE;

ADENOVIRUS; ADULT; AGE; BLOOD ANALYSIS; COMORBIDITY; CONSERVATIVE TREATMENT; CORRELATION ANALYSIS; DRUG EFFICACY; EPSTEIN BARR VIRUS; FECES ANALYSIS; FEMALE; HANTAVIRUS; HUMAN; IMMUNOCOMPETENCE; INFLUENZA VIRUS A; MALE; MEASLES VIRUS; MEDICAL LITERATURE; MORTALITY; NASOPHARYNX; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SEX DIFFERENCE; SYMPTOM; TREATMENT OUTCOME; URINALYSIS; VARICELLA ZOSTER VIRUS; VIRUS LOAD; VIRUS PNEUMONIA;

EID: 5044241481     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.07.010     Document Type: Article

References (109)

1. Y. Guan B.J. Zheng Y.Q. et al. He Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China Science 302 2003 276-278
2. R.G. Webster Wet markets - a continuing source of severe acute respiratory syndrome and influenza? Lancet 363 2004 234-236
3. S.M. Poutanen D.E. Low B. Henry et al. Identification of severe acute respiratory syndrome in Canada N Engl J Med 348 2003 1995-2005
4. K.W. Tsang P.L. Ho G.C. Ooi A et al. cluster of cases of severe acute respiratory syndrome in Hong Kong N Engl J Med 348 2003 1977-1985
5. J.S. Peiris S.T. Lai L.L. Poon et al. Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 2003 1319-1325
6. K.Y. Yuen P.K. Chan M. Peiris et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus Lancet 351 1998 467-471
7. T.H. Tran T.L. Nguyen T.D. Nguyen et al. Avian influenza A (H5N1) in 10 patients in Vietnam N Engl J Med 350 2004 1179-1188
8. J.S. Peiris C.M. Chu V.C. Cheng et al. Clinical progression and virus load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Lancet 361 2003 1767-1772
9. World Health Organization. Summary table of SARS cases by country 1 November 2002-7 http://www.who.int/csr/sars/country/en/ country2003_08_15.pdf Accessed March 25 2004
10. C.M. Chu V.C. Cheng I.F. Hung et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Thorax 59 2004 252-256
11. D. Cyranoski Critics slam treatment for SARS as ineffective and perhaps dangerous Nature 423 2003 4
12. S.R. Knowles E.J. Phillips L. Dresser L. Matukas Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada Clin Infect Dis 37 2003 1139-1142
13. Y. Oba The use of corticosteroids in SARS N Engl J Med 348 2003 2034-2035
14. G.R. Bernard Corticosteroids: the 'terminator' of all untreatable serious pulmonary illness Am J Respir Crit Care Med 168 2003 1409-1410
15. K.H. Chan L.L. Poon V.C. Cheng et al. Detection of SARS coronavirus in patients with suspected SARS Emerg Infect Dis 10 2004 294-299
16. V.C. Cheng I.F. Hung B.S. Tang et al. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome Clin Infect Dis 38 2004 467-475
17. G.J. Taylor W. Brenner W.R. Summer Severe viral pneumonia in young adults Chest 69 1976 722-728
18. R.H. Winterbauer W.R. Ludwig S.P. Hammar Clinical course, management, and long-term sequelae of respiratory failure due to influenza viral pneumonia Johns Hopkins Med J 141 1977 148-155
19. E.C. Oliveira P.E. Marik G. Colice Influenza pneumonia: a descriptive study Chest 119 2001 1717-1723
20. T. Kawayama R. Fujiki T. Rikimaru K. Oizumi Clinical study of severe influenza virus pneumonia that caused acute respiratory failure Kurume Med J 48 2001 273-279
21. J.E. Ferstenfeld D.P. Schlueter M.W. Rytel R.P. Molloy Recognition and treatment of adult respiratory distress syndrome secondary to viral interstitial pneumonia Am J Med 58 1975 709-718
22. I.A. Greaves H.J. Colebatch T.A. Torda A possible role for corticosteroids in the treatment of influenzal pneumonia Aust N Z J Med 11 1981 271-276
23. M. Doi S. Takao K. Kaneko et al. Two cases of severe bronchopneumonia due to influenza A (H3N2) virus: detection of influenza virus gene using reverse transcription polymerase chain reaction Intern Med 40 2001 61-67
24. P.K. Chan Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997 Clin Infect Dis 34 Suppl 2 2002 S58-S64
25. J.S. Peiris W.C. Yu C.W. Leung et al. Re-emergence of fatal human influenza A subtype H5N1 disease Lancet 363 2004 617-619
26. R.S. Hockberger R.J. Rothstein Varicella pneumonia in adults: a spectrum of disease Ann Emerg Med 15 1986 931-934
27. R.N. Davidson W. Lynn P. Savage M.H. Wansbrough-Jones Chickenpox pneumonia: experience with antiviral treatment Thorax 43 1988 627-630
28. A. Nilsson A. Ortqvist Severe varicella pneumonia in adults in Stockholm County 1980-1989 Scand J Infect Dis 28 1996 121-123
29. M. Mer G.A. Richards Corticosteroids in life-threatening varicella pneumonia Chest 114 1998 426-431
30. H.F. Laufenburg Varicella pneumonia: a case report and review Am Fam Physician 50 1994 793-796
31. H.M. Oh S.K. Chew Varicella pneumonia in adults-clinical spectrum Ann Acad Med Singapore 25 1996 816-819
32. K.A. DeVaul C.E. Garner Varicella-zoster virus pneumonia in the adult patient J Emerg Nurs 23 1997 102-104
33. P.D. Potgieter J.M. Hammond Intensive care management of varicella pneumonia Respir Med 91 1997 207-212
34. D. Schlossberg M. Littman Varicella pneumonia Arch Intern Med 148 1988 1630-1632
35. N. El-Daher R. Magnussen R.F. Betts Varicella pneumonitis: clinical presentation and experience with acyclovir treatment in immunocompetent adults Int J Infect Dis 2 1998 147-151
36. D.W. Chou C.H. Lee C.W. Chen H.Y. Chang T.R. Hsiue Varicella pneumonia complicated by acute respiratory distress syndrome in an adult J Formos Med Assoc 98 1999 778-782
37. P.A. Nee P.J. Edrich Chickenpox pneumonia: case report and literature review J Accid Emerg Med 16 1999 147-150
38. N.C. Hepburn R.H. Carley Adult respiratory distress syndrome secondary to varicella infection in a young adult J R Army Med Corps 135 1989 81-83
39. L.G. Lau Adult varicella pneumonia that responded to combined acyclovir and steroid therapy Med J Malaysia 54 1999 270-272
40. J. Keane B. Gochuico J.M. Kasznica H. Kornfeld Usual interstitial pneumonitis responsive to corticosteroids following varicella pneumonia Chest 113 1998 249-251
41. R. Ahmed Q.A. Ahmed N.A. Adhami Z.A. Memish Varicella pneumonia: another 'steroid responsive' pneumonia? J Chemother 14 2002 220-222
42. T. Shirai K. Sano S. Matsuyama et al. Varicella pneumonia in a healthy adult presenting with severe respiratory failure Intern Med 35 1996 315-318
43. O. Tokat N. Kelebek G. Turker S.F. Kahveci B. Ozcan Intravenous immunoglobulin in adult varicella pneumonia complicated by acute respiratory distress syndrome J Int Med Res 29 2001 252-255
44. B.A. Dudding S.C. Wagner J.A. Zeller J.T. Gmelich G.R. French F.H. Top Jr Fatal pneumonia associated with adenovirus type 7 in three military trainees N Engl J Med 286 1972 1289-1292
45. R.D. Pearson W.J. Hall M.A. Menegus R.G. Douglas Jr. Diffuse pneumonitis due to adenovirus type 21 in a civilian Chest 78 1980 107-109
46. P. Retalis C. Strange R. Harley The spectrum of adult adenovirus pneumonia Chest 109 1996 1656-1657
47. J.R. Klinger M.P. Sanchez L.A. Curtin M. Durkin B. Matyas Multiple cases of life-threatening adenovirus pneumonia in a mental health care center Am J Respir Crit Care Med 157 1998 645-649
48. Two fatal cases of adenovirus-related illness in previously healthy young adults-illinois, 2000 MMWR Morb. Mortal. Wkly. Rep. 2001 50 553-555
49. S. Levin J. Dietrich J. Guillory Fatal nonbacterial pneumonia associated with Adenovirus type 4. Occurrence in an adult JAMA 201 1967 975-977
50. A.L. Zarraga F.T. Kerns L.W. Kitchen Adenovirus pneumonia with severe sequelae in an immunocompetent adult Clin Infect Dis 15 1992 712-713
51. H. Levy S.Q. Simpson Hantavirus pulmonary syndrome Am J Respir Crit Care Med 149 1994 1710-1713
52. C. Castillo J. Naranjo A. Sepulveda G. Ossa H. Levy Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults Chest 120 2001 548-554
53. R. Riquelme M. Riquelme A. Torres et al. Hantavirus pulmonary syndrome, southern Chile Emerg Infect Dis 9 2003 1438-1443
54. L.E. Chapman B.A. Ellis F.T. Koster et al. Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome Clin Infect Dis 34 2002 293-304
55. L.E. Chapman G.J. Mertz C.J. Peters et al. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group Antivir Ther 4 1999 211-219
56. R.B. Aylward D.R. Burdge Ribavirin therapy of adult respiratory syncytial virus pneumonitis Arch Intern Med 151 1991 2303-2304
57. M.E. Rupp M.L. Schwartz D.E. Bechard Measles pneumonia. Treatment of a near-fatal case with corticosteroids and vitamin A Chest 103 1993 1625-1626
58. A. Haller L. von Segesser P.C. Baumann M. Krause Severe respiratory insufficiency complicating Epstein-Barr virus infection: case report and review Clin Infect Dis 21 1995 206-209
59. L.K. So A.C. Lau L.Y. Yam et al. Development of a standard treatment protocol for severe acute respiratory syndrome Lancet 361 2003 1615-1617
60. K.W. Choi T.N. Chau O. Tsang et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong Ann Intern Med 139 2003 715-723
61. Z. Zhao F. Zhang M. Xu et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China J Med Microbiol 52 2003 715-720
62. N. Lee D. Hui A. Wu et l. A major outbreak of severe acute respiratory syndrome in Hong Kong N Engl J Med 348 2003 1986-1994
63. J.C. Ho G.C. Ooi T.Y. Mok et al. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome Am J Respir Crit Care Med 168 2003 1449-1456
64. K.S. Chan S.T. Lai C.M. Chu et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study Hong Kong Med J 9 2003 399-406
65. M.R. Loutfy L.M. Blatt K.A. Siminovitch et al. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study JAMA 290 2003 3222-3228
66. L.Y. Hsu C.C. Lee J.A. Green et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts Emerg Infect Dis 9 2003 713-717
67. V.W. Wong D. Dai A.K. Wu J.J. Sung Treatment of severe acute respiratory syndrome with convalescent plasma Hong Kong Med J 9 2003 199-201
68. Sever acute respiratory syndroms (SARS) and coronavirus testing - United States, 2003 MMWR Morb. Mortal. Wkly. Rep. 2003 52 297-302
69. Update: Severe acute respiratory syndrome - United States, 2003 MMWR Morb. Mortal. Wkly. Rep. 2003 52 332 334-336
70. Update: Severe acute respiratory syndrome - United States, 2003 MMWR Morb. Mortal. Wkly. Rep. 2003 52 334-360
71. Update: Severe acute respiratory syndrome - United States, June 11, 2003 MMWR Morb. Mortal. Wkly. Rep. 2003 52 550
72. C.M. Booth L.M. Matukas G.A. Tomlinson et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area JAMA 289 2003 2801-2809
73. R. Dolin Influenza: current concepts Am Fam Physician 14 1976 72-77
74. A.R. Falsey M.A. Formica J.J. Treanor E.E. Walsh Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding J Clin Microbiol 41 2003 4160-4165
75. T.M. File Community-acquired pneumonia Lancet 362 2003 1991-2001
76. A. Ruiz-Gonzalez M. Falguera A. Nogues M. Rubio-Caballero Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia Am J Med 106 1999 385-390
77. T. Ishida T. Hashimoto M. Arita I. Ito M. Osawa Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan Chest 114 1998 1588-1593
78. G.K. Robbins V. De Gruttola R.W. Shafer et al. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection N Engl J Med 349 2003 2293-2303
79. R.W. Shafer L.M. Smeaton G.K. Robbins et al. Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection N Engl J Med 349 2003 2304-2315
80. E. Jaeckel M. Cornberg H. Wedemeyer et al. Treatment of acute hepatitis C with interferon alfa-2b N Engl J Med 345 2001 1452-1457
81. M.W. Fried M.L. Shiffman K.R. Reddy et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975-982
82. M.P. Manns J.G. McHutchison S.C. Gordon et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958-965
83. C.L. Lai R.N. Chien N.W. Leung et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group N Engl J Med 339 1998 61-68
84. J.L. Dienstag E.R. Schiff T.L. Wright et al. Lamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 341 1999 1256-1263
85. P.A. Leone S. Trottier J.M. Miller Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment Clin Infect Dis 34 2002 958-962
86. L. Corey A. Wald R. Patel et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes N Engl J Med 350 2004 11-20
87. H.H. Balfour Jr H.A. Rotbart S. Feldman et al. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group J Pediatr 120 1992 627-633
88. M.R. Wallace W.A. Bowler N.B. Murray S.K. Brodine E.C. Oldfield 3rd Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial Ann Intern Med 117 1992 358-363
89. D. Salmon-Ceron A.M. Fillet J.P. Aboulker et al. Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group Clin Infect Dis 28 1999 901-905
90. D.F. Martin J. Sierra-Madero S. Walmsley et al. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis N Engl J Med 346 2002 1119-1126
91. K.G. Nicholson F.Y. Aoki A.D. Osterhaus et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group Lancet 355 2000 1845-1850
92. J.J. Treanor F.G. Hayden P.S. Vrooman et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group JAMA 283 2000 1016-1024
93. J.A. Hedrick A. Barzilai U. Behre et al. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial Pediatr Infect Dis J 19 2000 410-417
94. L.J. Eron C. Toy B. Salsitz R.R. Scheer D.L. Wood P.I. Nadler Therapy of genital herpes with topically applied interferon Antimicrob Agents Chemother 31 1987 1137-1139
95. M.J. Levin F.N. Judson L. Eron et al. Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences Antimicrob Agents Chemother 33 1989 649-652
96. F.W. Moler C.M. Steinhart S.E. Ohmit G.L. Stidham Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group J Pediatr 128 1996 422-428
97. A.M. Guerguerian M. Gauthier M.H. Lebel C.A. Farrell J. Lacroix Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial Am J Respir Crit Care Med 160 1999 829-834
98. Hung I.F. Cheng V.C. Wu A.K. et al. Viral loads in clinical specimens and SARS manifestations. Emerg. Infect. Dis. 2004 in press.
99. G. Koren S. King S. Knowles E. Phillips Ribavirin in the treatment of SARS: a new trick for an old drug? CMAJ 168 2003 1289-1292
100. Q. Ning D. Brown J. Parodo et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response J Immunol 160 1998 3487-3493
101. E.L. Tan E.E. Ooi C.Y. Lin et al. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs Emerg Infect Dis 10 2004 581-586
102. D.F. Smee M. Bray J.W. Huggins Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro Antivir Chem Chemother 12 2001 327-335
103. J. Cinatl B. Morgenstern G. Bauer P. Chandra H. Rabenau H.W. Doerr Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Lancet 361 2003 2045-2046
104. J. Cinatl B. Morgenstern G. Bauer P. Chandra H. Rabenau H.W. Doerr Treatment of SARS with human interferons Lancet 362 2003 293-294
105. F. Chen K.H. Chan Y. Jiang et al. In vitro susceptibility of ten clinical isolates of SARS coronavirus to selected antiviral compounds J Clin Virol 31 2004 69-75
106. K.S. Kumar M.W. Russo A.C. Borczuk et al. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C Am J Gastroenterol 97 2002 2432-2440
107. B.L. Haagmans T. Kuiken B.E. Martina et al. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques Nat Med 10 2004 290-293
108. L.E. Hensley L.E. Fritz P.B. Jahrling C.L. Karp J.W. Huggins T.W. Geisbert Interferon-beta 1a and SARS coronavirus replication Emerg Infect Dis 10 2004 317-319
109. Stroher U. DiCaro A. Li Y. et al. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon alpha J Infect Dis 2004 189 1164-1167